Bir Dawn Carter
Officer at REATA PHARMACEUTICALS INC
- Sold, on record
- $26.1M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Aug 16, 2023
- Form 144 notices
- 6
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- REATA PHARMACEUTICALS INCOfficer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice REATA PHARMACEUTICALS INCNoticeMay 16, 2023 2023
Filed to sell 417 shares ($34k)
Bir Dawn Carter, Officer
No 10b5-1 plan0x usual sizeFiling
- 2 Form 4 sale REATA PHARMACEUTICALS INCNo planMay 16, 2023 same day
Sold 1,311 shares at $83.78 ($110k)
Bir Dawn Carter, Chief Commercial Officer
No 10b5-1 planSold 4.1% of holdings ($2.7M position)30,885 shares left0.1x usual sizeFollows a Form 144Filing
- 3 Form 144 notice REATA PHARMACEUTICALS INCNoticeJul 28, 2023 +73 days
Filed to sell 20,000 shares ($3.3M)
Bir Dawn Carter, Officer
10b5-1 plan3.5x usual sizeFiling
- 4 Form 144 notice REATA PHARMACEUTICALS INCNoticeJul 28, 2023 same day
Filed to sell 20,000 shares ($3.3M)
Bir Dawn Carter, Officer
10b5-1 plan3.5x usual sizeFiling
- 5 Form 4 sale REATA PHARMACEUTICALS INCUnusualJul 28, 2023 same day
Sold 40,000 shares at $164.54 ($6.6M)
Bir Dawn Carter, Chief Commercial Officer
10b5-1 planSold 53.3% of holdings ($12.3M position)35,010 shares left7x usual sizeFollows a Form 144Filing
- 6 Form 144 notice REATA PHARMACEUTICALS INCNoticeAug 15, 2023 +18 days
Filed to sell 807 shares ($136k)
Bir Dawn Carter, Officer
No 10b5-1 plan0.1x usual sizeFiling
- 7 Form 144 notice REATA PHARMACEUTICALS INCNoticeAug 16, 2023 +1 day
Filed to sell 398 shares ($67k)
Bir Dawn Carter, Officer
No 10b5-1 plan0x usual sizeFiling
- 8 Form 4 sale REATA PHARMACEUTICALS INCNo planAug 16, 2023 same day
Sold 1,205 shares at $168.81 ($203k)
Bir Dawn Carter, Chief Commercial Officer
No 10b5-1 planSold 3.4% of holdings ($5.9M position)33,805 shares left0.1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | Aug 17, 2023 | REATA PHARMACEUTICALS INC | Chief Commercial Officer | Form 4 sale | 1,205 | $203k | 3.4% | No plan | SEC |
| Aug 16, 2023 | Aug 16, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 398 | $67k | Notice | SEC | |
| Aug 15, 2023 | Aug 15, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 807 | $136k | Notice | SEC | |
| Jul 28, 2023 | Aug 1, 2023 | REATA PHARMACEUTICALS INC | Chief Commercial Officer | Form 4 sale | 40,000 | $6.6M | 53.3% | Unusual | SEC |
| Jul 28, 2023 | Jul 28, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 20,000 | $3.3M | Notice | SEC | |
| Jul 28, 2023 | Jul 28, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 20,000 | $3.3M | Notice | SEC | |
| May 16, 2023 | May 17, 2023 | REATA PHARMACEUTICALS INC | Chief Commercial Officer | Form 4 sale | 1,311 | $110k | 4.1% | No plan | SEC |
| May 16, 2023 | May 16, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 417 | $34k | Notice | SEC | |
| May 15, 2023 | May 15, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 894 | $76k | Notice | SEC | |
| Mar 13, 2023 | Mar 15, 2023 | REATA PHARMACEUTICALS INC | Chief Commercial Officer | Form 4 sale | 9,317 | $808k | 22.4% | Plan not stated | SEC |
| Mar 7, 2023 | Mar 8, 2023 | REATA PHARMACEUTICALS INC | Chief Commercial Officer | Form 4 sale | 96,996 | $8.5M | 70.0% | Unusual | SEC |
| Mar 3, 2023 | Mar 6, 2023 | REATA PHARMACEUTICALS INC | Chief Commercial Officer | Form 4 sale | 2,166 | $191k | 4.3% | Plan not stated | SEC |
| Nov 9, 2020 | Nov 10, 2020 | REATA PHARMACEUTICALS INC | Chief Commercial Officer | Form 4 sale | 60,000 | $9.8M | 100.0% | Unusual | SEC |